FDA Approves Lodoco (colchicine) as the First Anti-Inflammatory Drug for Cardiovascular Disease

Parsippany, NJ– June 20, 2023– AGEPHA Pharma USA, LLC, today announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Lodoco® as the first anti-inflammatory atheroprotective...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news